Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

Impact of severe malnutrition on short-term mortality and overall survival in head and neck cancer.

Datema FR, Ferrier MB, Baatenburg de Jong RJ.

Oral Oncol. 2011 Sep;47(9):910-4. doi: 10.1016/j.oraloncology.2011.06.510. Epub 2011 Jul 28.

PMID:
21802345
2.

Impact of comorbidity on short-term mortality and overall survival of head and neck cancer patients.

Datema FR, Ferrier MB, van der Schroeff MP, Baatenburg de Jong RJ.

Head Neck. 2010 Jun;32(6):728-36. doi: 10.1002/hed.21245.

PMID:
19827120
3.

Prediction of survival in patients with head and neck cancer.

Baatenburg de Jong RJ, Hermans J, Molenaar J, Briaire JJ, le Cessie S.

Head Neck. 2001 Sep;23(9):718-24.

PMID:
11505480
4.

Impact of comorbidity on outcome of young patients with head and neck squamous cell carcinoma.

Singh B, Bhaya M, Zimbler M, Stern J, Roland JT, Rosenfeld RM, Har-El G, Lucente FE.

Head Neck. 1998 Jan;20(1):1-7.

PMID:
9464945
5.

Novel head and neck cancer survival analysis approach: random survival forests versus Cox proportional hazards regression.

Datema FR, Moya A, Krause P, Bäck T, Willmes L, Langeveld T, Baatenburg de Jong RJ, Blom HM.

Head Neck. 2012 Jan;34(1):50-8. doi: 10.1002/hed.21698. Epub 2011 Feb 14.

PMID:
21322080
6.

Importance of comorbidity in head and neck cancer.

Piccirillo JF.

Laryngoscope. 2000 Apr;110(4):593-602.

PMID:
10764003
7.

Comorbidity measurement in patients with laryngeal squamous cell carcinoma.

Castro MA, Dedivitis RA, Ribeiro KC.

ORL J Otorhinolaryngol Relat Spec. 2007;69(3):146-52. Epub 2007 Jan 30.

PMID:
17264530
8.

Therapeutic decision making in stages III and IV head and neck squamous cell carcinoma.

Gleich LL, Collins CM, Gartside PS, Gluckman JL, Barrett WL, Wilson KM, Biddinger PW, Redmond KP.

Arch Otolaryngol Head Neck Surg. 2003 Jan;129(1):26-35.

PMID:
12525191
9.

Racial disparities in patients with head and neck squamous cell carcinoma.

Gourin CG, Podolsky RH.

Laryngoscope. 2006 Jul;116(7):1093-106. Erratum in: Laryngoscope. 2006 Nov;116(11):2098.

PMID:
16826042
10.

A matched control study of treatment outcome in young patients with squamous cell carcinoma of the head and neck.

Verschuur HP, Irish JC, O'Sullivan B, Goh C, Gullane PJ, Pintilie M.

Laryngoscope. 1999 Feb;109(2 Pt 1):249-58.

PMID:
10890775
11.

Aspects of survival from colorectal cancer in Denmark.

Iversen LH.

Dan Med J. 2012 Apr;59(4):B4428.

PMID:
22459726
12.

Effect of comorbidity on quality of life and treatment selection in patients with squamous cell carcinoma of the head and neck.

Gourin CG, McAfee WJ, Neyman KM, Howington JW, Podolsky RH, Terris DJ.

Laryngoscope. 2005 Aug;115(8):1371-5.

PMID:
16094107
13.

Second cancer incidence, risk factor, and specific mortality in head and neck squamous cell carcinoma.

Lee DH, Roh JL, Baek S, Jung JH, Choi SH, Nam SY, Kim SY.

Otolaryngol Head Neck Surg. 2013 Oct;149(4):579-86. doi: 10.1177/0194599813496373. Epub 2013 Jul 2.

PMID:
23820107
14.

Survival patterns in squamous cell carcinoma of the head and neck: pain as an independent prognostic factor for survival.

Reyes-Gibby CC, Anderson KO, Merriman KW, Todd KH, Shete SS, Hanna EY.

J Pain. 2014 Oct;15(10):1015-22. doi: 10.1016/j.jpain.2014.07.003. Epub 2014 Jul 17.

15.

p53 expressions: predicting recurrence and second primary tumors in head and neck squamous cell carcinoma.

Shin DM, Lee JS, Lippman SM, Lee JJ, Tu ZN, Choi G, Heyne K, Shin HJ, Ro JY, Goepfert H, Hong WK, Hittelman WN.

J Natl Cancer Inst. 1996 Apr 17;88(8):519-29.

PMID:
8606380
16.

The impact of comorbidity on outcome in 12 623 Danish head and neck cancer patients: a population based study from the DAHANCA database.

Bøje CR, Dalton SO, Grønborg TK, Primdahl H, Kristensen CA, Andersen E, Johansen J, Andersen LJ, Overgaard J.

Acta Oncol. 2013 Feb;52(2):285-93. doi: 10.3109/0284186X.2012.742964.

PMID:
23320773
17.

Prognostic impact of pretherapeutic laboratory values in head and neck cancer patients.

Peter F, Wittekindt C, Finkensieper M, Kiehntopf M, Guntinas-Lichius O.

J Cancer Res Clin Oncol. 2013 Jan;139(1):171-8. doi: 10.1007/s00432-012-1320-1. Epub 2012 Sep 25.

PMID:
23007690
18.

A novel classification system for perineural invasion in noncutaneous head and neck squamous cell carcinoma: histologic subcategories and patient outcomes.

Miller ME, Palla B, Chen Q, Elashoff DA, Abemayor E, St John MA, Lai CK.

Am J Otolaryngol. 2012 Mar-Apr;33(2):212-5. doi: 10.1016/j.amjoto.2011.06.003. Epub 2011 Dec 15.

PMID:
22177613
19.

Prognostic factors for survival after salvage reirradiation of head and neck cancer.

Tanvetyanon T, Padhya T, McCaffrey J, Zhu W, Boulware D, Deconti R, Trotti A.

J Clin Oncol. 2009 Apr 20;27(12):1983-91. doi: 10.1200/JCO.2008.20.0691. Epub 2009 Mar 16.

PMID:
19289616
20.

Prediction of survival by pretreatment health-related quality-of-life scores in a prospective cohort of patients with head and neck squamous cell carcinoma.

Østhus AA, Aarstad AK, Olofsson J, Aarstad HJ.

JAMA Otolaryngol Head Neck Surg. 2013 Jan;139(1):14-20. doi: 10.1001/jamaoto.2013.1056.

PMID:
23329087

Supplemental Content

Support Center